From Survey Results to a Decision-Making Matrix for Strategic Planning in Healthcare: The Case of Clinical Pathways.
COVID-19
clinical pathways
comparison tool
healthcare system
strategic planning
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
25 06 2022
25 06 2022
Historique:
received:
17
05
2022
revised:
21
06
2022
accepted:
21
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
It is a well-known fact that the information obtained from a survey can be used in a healthcare organizational analysis; however, it is very difficult to compare the different results found in the literature to each other, even through the use of metanalysis, as the methodology is often not consistent. Data from a survey analyzing the organizational and managerial responses adopted in pathology-specific clinical pathways (CPs) during the first two waves of the COVID-19 pandemic were used for constructing a decisional matrix, a tool called SPRIS system, consisting of four different sheets. The first sheet reports the results of the survey and, using a streetlight color system, identifies strengths and weaknesses; the second one, by assigning a priority score, establishes the priority of intervention on each of the strengths and weaknesses identified; the third sheet reports the subjective items of the questionnaire in order to identify threats and opportunities and their probability of happening; in the last sheet, a SWOT Analysis is used to calculate the performance index of the whole organization. The SPRIS system, applied to data concerning the adaptation of four CPs to the COVID-19 pandemic, showed that, whereas all the CPs had a good performance index, some concerns remained unsolved and need be addressed. The SPRIS system showed to be an easily constructed tool that is able to give an overview of the organization analyzed by the survey and to produce an index that can be used in a direct quality comparison between different services or organizations.
Sections du résumé
BACKGROUND
It is a well-known fact that the information obtained from a survey can be used in a healthcare organizational analysis; however, it is very difficult to compare the different results found in the literature to each other, even through the use of metanalysis, as the methodology is often not consistent.
METHODS
Data from a survey analyzing the organizational and managerial responses adopted in pathology-specific clinical pathways (CPs) during the first two waves of the COVID-19 pandemic were used for constructing a decisional matrix, a tool called SPRIS system, consisting of four different sheets. The first sheet reports the results of the survey and, using a streetlight color system, identifies strengths and weaknesses; the second one, by assigning a priority score, establishes the priority of intervention on each of the strengths and weaknesses identified; the third sheet reports the subjective items of the questionnaire in order to identify threats and opportunities and their probability of happening; in the last sheet, a SWOT Analysis is used to calculate the performance index of the whole organization.
RESULTS
The SPRIS system, applied to data concerning the adaptation of four CPs to the COVID-19 pandemic, showed that, whereas all the CPs had a good performance index, some concerns remained unsolved and need be addressed.
CONCLUSIONS
The SPRIS system showed to be an easily constructed tool that is able to give an overview of the organization analyzed by the survey and to produce an index that can be used in a direct quality comparison between different services or organizations.
Identifiants
pubmed: 35805466
pii: ijerph19137806
doi: 10.3390/ijerph19137806
pmc: PMC9265412
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2011;6(7):e21704
pubmed: 21818262
Trop Med Int Health. 2015 Dec;20(12):1756-70
pubmed: 26425920
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Nov;108(5):647-55
pubmed: 19836721
Curr Pharm Biotechnol. 2019;20(8):643-652
pubmed: 30961489
Eur J Cancer. 2020 Jun;132:17-23
pubmed: 32311643
Front Public Health. 2020 Sep 22;8:457
pubmed: 33072683
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):351-354
pubmed: 32311652
PLoS Med. 2010 Jan 26;7(1):e1000223
pubmed: 20126260
Indian J Anaesth. 2021 Oct;65(10):768-770
pubmed: 34898708
Wien Klin Wochenschr. 2020 Jul;132(13-14):356-361
pubmed: 32435867
Int J Environ Res Public Health. 2020 May 27;17(11):
pubmed: 32471066
Milbank Q. 2005;83(4):691-729
pubmed: 16279964
Int J Environ Res Public Health. 2022 Mar 24;19(7):
pubmed: 35409567
Health Qual Life Outcomes. 2006 Dec 07;4:94
pubmed: 17156420
BMC Med Inform Decis Mak. 2016 Nov 8;16(1):141
pubmed: 27825333
BMJ Open. 2017 Jun 8;7(6):e014840
pubmed: 28600367
Int J Environ Res Public Health. 2022 Jan 06;19(2):
pubmed: 35055455
Transl Behav Med. 2019 Jan 1;9(1):1-10
pubmed: 29346635
Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2089-94
pubmed: 25267553
Prim Care Diabetes. 2021 Feb;15(1):16-17
pubmed: 32535088
J Soc Psychol. 1965 Dec;67(2):189-96
pubmed: 5841079
Indian J Community Med. 2020 Jul-Sep;45(3):381
pubmed: 33354025
Am J Public Health. 2012 Sep;102(9):1697-705
pubmed: 22813417
J R Soc Med. 2003 Sep;96(9):429-31
pubmed: 12949196
Int J Environ Res Public Health. 2021 Oct 16;18(20):
pubmed: 34682618
Health Policy. 2021 Sep;125(9):1179-1187
pubmed: 34366171
Int J Environ Res Public Health. 2021 May 25;18(11):
pubmed: 34070427
BMC Infect Dis. 2014 Nov 15;14:595
pubmed: 25398412
Sci Total Environ. 2010 Sep 1;408(19):4045-51
pubmed: 20547411
Eur J Public Health. 2017 Jun 1;27(3):421-424
pubmed: 28115421
Eur J Cancer. 2021 May;148:112-116
pubmed: 33743478
Implement Sci. 2019 Jun 6;14(1):57
pubmed: 31171004
Open Heart. 2020 Aug;7(2):
pubmed: 32855212
Acta Biomed. 2021 Feb 09;92(1):e2021093
pubmed: 33682818
J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102166
pubmed: 34033966